Skip to main content
# Title Research Year
71 Musculoskeletal ultrasound; the third eye of the rheumatologist. 2018
72 Response of Chronic myeloid leukemia’s patient to different types of tyrosine kinase inhibitors 2018
73 Prognostic Factors in Advanced Non-Small Cell Lung
Cancer and Their Relation to Clinical Outcomes
2017
74 The Efficacy of Denosumab versus Zoledronic Acid in Preventing
Skeletal Related Events in Cancer Patients with Bone Metastasis
2017
75 Technetium-99m pentavalent dimercaptosuccinic acid (99mTc-DMSA-V) brain SPECT/CT and Karnofsky performance score predict survival in patients with glioma 2017
76 Survival of High Grade Glioma Patients Treated by Three Radiation Schedules
with Chemotherapy: A Retrospective Comparative Study
2017
77 The Efficacy of Denosumab versus Zoledronic Acid in Preventing
Skeletal Related Events in Cancer Patients with Bone Metastasis
2017
78 Technetium-99m pentavalent dimercaptosuccinic acid (99mTc-DMSA-V) brain SPECT/CT and Karnofsky performance score predict survival in patients with glioma 2017
79 Survival of High Grade Glioma Patients Treated by Three Radiation Schedules
with Chemotherapy: A Retrospective Comparative Study
2017
80 Brain SPECT/CT scanning with technetium-99m pentavalent dimercaptosuccinic acid [DMSA (V)] is an accurate tool for post-treatment evaluation of patients with glioma. 2017